(Manuscript not received.] Discussion. Flieringa asked whether in the patient with the cured pulmonary focus, a careful search had been carried out for possible lymph node involvement, and further, whether the series of patients who were discussed last did not show the Schwarzmann phenomenon. Manschot: Has the speaker also experience with regard to the frequency of toxoplasmosis as an aetiological factor in chronic uveitis? The literature gives the impression that we now live in the toxoplasmosis era. In one patient toxoplasma could be cultivated from a cervical lymph node. Especially in the beginning of the ocular disease, a few recurrences were accompanied by lymph node enlargement. These were localized in the left half 474
foci of low vitality. These foci may exist in the depths of the tonsils, and are usually not detectable by smears. However, they cause a rise in the L-titre and the O-titre. Binkhorst replied to Flieringa: Apart from a small cervical lymphoma, no abnormalities have been found in the patient. The lymphoma was interpreted as a result of chronic tonsillitis. This communication was exclusively meant to draw the attention to the occurrence of a parallelism between increases in the titre of the serum and the development of general and local symptoms, with a fresh, clinically demonstrable inflammation reaction of the eye. The question whether this reaction is part of a general Schwarzmann phenomenon can only be answered when more criteria will be available. Rectification. Is Retrolental Fibroplasia Rare in Switzerland? (Ophthalmologica 133, 1 [1957] ) by Robert H.Fenton. We must excuse ourselves for having overlooked an excellent work on Retrolental Fibroplasia done by Dr. Ellen Bing at the Ophthalmology Clinic of the University of Basel (Prof. F. Rintelen). In this paper Dr. Bing discussed a second certain case of Retrolental Fibroplasia in a child born in Switzerland (Annales Paediatrici, 184-, 294 [1955] ). The conclusions drawn by Dr. Bing are essentially the same as our own with, however, one notable exception. According to her thesis, the premature mortality rate in Switzerland would appear to be the same as that in the United States. We feel that sufficient evidence has now been advanced to indicate that the mortality of low weight prematures is higher in Switzerland than in the United States. This criticism, however, does not in any way detract from the real value of Dr. Bing's work, and it is to be regretted that her work was overlooked before this time. 
